2 FUTURENORTH BIONOW AWARDS
2018 Bionow Award winners
6 March 2019
Medtech companies triumph at Bionow Awards
Reflecting “superb efforts” by life sciences companies in the North
The outstanding companies and lead- ers of the North’s life sciences sector were honoured at the 17th annual Bionow Awards. The awards, which recognise excellence, outstanding achievement and enterprise in a sector that is worth more than £13bn to the North’s economy, were sponsored by Manchester Science Partnerships, Alderley Park, Appleyard Lees, DLA Piper and World Courier. Entertained by writer, comedian
and actor Robin Ince, more than 300 people attended the awards dinner in Cheshire, which saw medical technol- ogy companies, Blueberry Therapeu- tics, C4X Discovery, Zilico and LightOx all win prizes for the application of their cutting edge technologies to the life sciences sector. Following a remarkable year, Blue-
berry Therapeutics received the sought- after Company of the Year award. Blueberry is applying nanotechnology to the delivery of medicines for difficult- to-treat skin and nail infections. C4X Discovery celebrated the only
double win on the night, achieving the Bionow Project of the Year award for the development of Orexin-1 Recep- tor Antagonists for the Treatment of Addiction, while its Lead Software
Developer Phil Muwanga won in the prestigious Promising Technologist of the Year category. Med-tech company Zilico won the In-
vestment Deal of the Year after raising £13.5m to roll-out the sales of its device ZedScan which detects life- threatening cervical cancer much earlier than cur- rent products on the market. Having developed a unique range
of molecular tools for use as biological fluorescent probes for cell imaging and targeted light-based therapeutics aimed at treating conditions such as skin and colorectal cancers, LightOx won in the Start-Up category.
Entrepreneur Alby Pattison took the
Outstanding Contribution Award on the night. Alby founded Hart Biologics in 2002 and during the last 15 years the business has grown into an award- winning medical diagnostics company which exports to 39 countries and is now a team of 43. The judges said he had “demon-
strated a level of dedication to the sector that goes above and beyond the call of duty, in addition to being a leader in their field, Alby has also given a significant amount back to business and the community.” Geoff Davison, chief executive of Bi-
“Despite the current uncertainty our innovative and adaptable community will continue to find ways to grow”
Geoff Davison, chief executive, Bionow
onow said: “Congratulations to all our winners and to those shortlisted - the 2018 Awards reflect the superb efforts by companies in the Life Sciences sector in the North to innovate and commercialise great ideas and IP into new medicines and treatments.” He added: “Despite the current un-
certainty in the market place regarding the nature and form of Brexit, and scar- city of funding in the North, I believe our innovative and adaptable commu- nity will continue to find ways to grow. Analysing recent Government figures, we found that the North’s life sciences economy grew from £9.2 billion in 2016 to £13.6 billion in 2017, representing an increase of 48% over the previous year which is 4.8% higher than the national average. I look forward to reporting on continued growth next year.”
The winners in full:
l Bionow Start Up of the Year - Sponsored by RSM LightOx Ltd LightOx Ltd is a light-based thera- peutics company that is developing new drugs that can be activated us- ing light sources to kill targeted cell types. These new chemical entities will be formulated into new drugs to treat conditions such as skin and colorectal cancers.
l Bionow Healthcare Project of the Year - Sponsored by TRUSTECH The Northern Health Science Alliance - Project: Connected Health Cities Connected Health Cities is a global programme harnessing the power of data to implement Learning Health Systems; to deliver improve- ments in systems, for patients. Using the innovative ‘CHC Method’ across multiple therapeutic areas to diagnose, treat and deliver care, the impact of CHC can now be measured in lives saved.
l Bionow Project of the Year – Sponsored by Waters Corporation C4X Discovery Ltd - Project: Development of Orexin-1
Receptor Antagonists for the Treatment of Addiction C4XD has identified C4X3256, a novel, potent and selective oral Orexin-1 antagonist for the treat- ment of addiction. C4X3256 has demonstrated excellent efficacy and tolerability in preclinical models of nicotine addiction, which has re- sulted in this project being licensed to Indivior who will continue the development of C4X3256 in the clinic.
l Bionow Product of the Year – Sponsored by Innovation Agency Femeda Ltd - Product: Pelviva – Pelvic Floor muscle re-trainer Pelviva is an innovative, clinically proven solution to the common problem of incontinence, deliver- ing 84% improvement in bladder control in 90 days. It uniquely brings together two new innovative technologies, a patented waveform which is incorporated into a home treatment device that is highly ac- ceptable to the female user.
l Bionow Technical Service – Sponsored by Gateley Plc Seda Pharmaceutical
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12
